Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Donnem

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Annals of Translational Medicine|May 11, 2016
Importance of tumor infiltrating lymphocytes in non-small cell lung cancer?Roy M Bremnes, Tom Donnem, Lill-Tove Busund
Rural and Remote Health|September 3, 2020
Evaluating a centralised cancer support centre in the remote region of Northern NorwayBente Ervik, Sigve Andersen, Helge Skirbekk, et al.
Cells|October 15, 2025
A Change of Hallmark: An UpdateTom Donnem, David Kerr, Leonid L Nikitenko, et al.
Palliative Medicine|April 15, 2006
Centralized inpatient palliative care units in remote areas: an obstacle to future home care?Tom Donnem, Tone Nordoy, Bente Ervik, et al.
Journal of Thoracic Disease|July 27, 2012
Gene expression assays as prognostic and predictive markers in early stage non-small cell lung cancerTom Donnem, Roy M Bremnes, Lill-Tove Busund, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 19, 2013
Sudden death by an atrial-esophageal fistulaeSigve Andersen, Tormod Eggen, Tom Donnem, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 26, 2009
Prognostic impact of fibroblast growth factor 2 in non-small cell lung cancer: coexpression with VEGFR-3 and PDGF-B predicts poor survivalTom Donnem, Khalid Al-Shibli, Samer Al-Saad, et al.
BMC Cancer|March 1, 2014
Stage and tissue-specific prognostic impact of miR-182 in NSCLCHelge Stenvold, Tom Donnem, Sigve Andersen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 19, 2010
The prognostic value of intraepithelial and stromal CD3-, CD117- and CD138-positive cells in non-small cell lung carcinomaKhalid Al-Shibli, Samer Al-Saad, Sigve Andersen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 11, 2009
Angiogenic markers show high prognostic impact on survival in marginally operable non-small cell lung cancer patients treated with adjuvant radiotherapySigve Andersen, Tom Donnem, Samer Al-Saad, et al.
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Annals of Translational Medicine|May 11, 2016
Importance of tumor infiltrating lymphocytes in non-small cell lung cancer?Roy M Bremnes, Tom Donnem, Lill-Tove Busund
Rural and Remote Health|September 3, 2020
Evaluating a centralised cancer support centre in the remote region of Northern NorwayBente Ervik, Sigve Andersen, Helge Skirbekk, et al.
Cells|October 15, 2025
A Change of Hallmark: An UpdateTom Donnem, David Kerr, Leonid L Nikitenko, et al.
Palliative Medicine|April 15, 2006
Centralized inpatient palliative care units in remote areas: an obstacle to future home care?Tom Donnem, Tone Nordoy, Bente Ervik, et al.
Journal of Thoracic Disease|July 27, 2012
Gene expression assays as prognostic and predictive markers in early stage non-small cell lung cancerTom Donnem, Roy M Bremnes, Lill-Tove Busund, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 19, 2013
Sudden death by an atrial-esophageal fistulaeSigve Andersen, Tormod Eggen, Tom Donnem, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 26, 2009
Prognostic impact of fibroblast growth factor 2 in non-small cell lung cancer: coexpression with VEGFR-3 and PDGF-B predicts poor survivalTom Donnem, Khalid Al-Shibli, Samer Al-Saad, et al.
BMC Cancer|March 1, 2014
Stage and tissue-specific prognostic impact of miR-182 in NSCLCHelge Stenvold, Tom Donnem, Sigve Andersen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 19, 2010
The prognostic value of intraepithelial and stromal CD3-, CD117- and CD138-positive cells in non-small cell lung carcinomaKhalid Al-Shibli, Samer Al-Saad, Sigve Andersen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 11, 2009
Angiogenic markers show high prognostic impact on survival in marginally operable non-small cell lung cancer patients treated with adjuvant radiotherapySigve Andersen, Tom Donnem, Samer Al-Saad, et al.
Pageof 10